Chahrazade Kantari‐Mimoun

2.0k total citations · 2 hit papers
11 papers, 1.3k citations indexed

About

Chahrazade Kantari‐Mimoun is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Chahrazade Kantari‐Mimoun has authored 11 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Chahrazade Kantari‐Mimoun's work include Cancer, Hypoxia, and Metabolism (4 papers), Phagocytosis and Immune Regulation (3 papers) and Immune Cell Function and Interaction (3 papers). Chahrazade Kantari‐Mimoun is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Phagocytosis and Immune Regulation (3 papers) and Immune Cell Function and Interaction (3 papers). Chahrazade Kantari‐Mimoun collaborates with scholars based in France, Germany and Austria. Chahrazade Kantari‐Mimoun's co-authors include Emmanuel Donnadieu, Sarah Barrin, Lene Vimeux, Marco Alifano, Nadège Bercovici, Diane Damotte, Audrey Lupo, Jean Lemoine, Vincent Feuillet and Marion V. Guérin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Chahrazade Kantari‐Mimoun

11 papers receiving 1.3k citations

Hit Papers

Macrophages impede CD8 T cells from reaching tumor cells ... 2018 2026 2020 2023 2018 2021 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment
    2018 631 citations Elisa Peranzoni, Jean Lemoine et al. Proceedings of the National Academy of Sciences profile →
  2. Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment
    2021 215 citations Alba Nicolás‐Boluda, Javier Vaquero et al. eLife profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chahrazade Kantari‐Mimoun France 10 766 680 388 186 140 11 1.3k
Liangrong Shi China 17 544 0.7× 663 1.0× 255 0.7× 180 1.0× 134 1.0× 33 1.2k
Ivy X. Chen United States 8 371 0.5× 560 0.8× 238 0.6× 131 0.7× 187 1.3× 10 947
Boxuan Zhou China 14 717 0.9× 438 0.6× 521 1.3× 299 1.6× 117 0.8× 40 1.4k
Crescenzo D’Alterio Italy 19 533 0.7× 849 1.2× 371 1.0× 186 1.0× 98 0.7× 36 1.3k
Kabir A. Khan United Kingdom 15 320 0.4× 489 0.7× 547 1.4× 217 1.2× 77 0.6× 21 1.2k
Adrià Cañellas‐Socias Spain 6 576 0.8× 1.0k 1.5× 493 1.3× 271 1.5× 78 0.6× 7 1.5k
Yosra Messai France 13 486 0.6× 505 0.7× 411 1.1× 453 2.4× 108 0.8× 23 1.2k
Jordi Badia-Ramentol Spain 6 588 0.8× 1.1k 1.6× 491 1.3× 298 1.6× 85 0.6× 7 1.5k
Ai Sato Japan 16 275 0.4× 592 0.9× 630 1.6× 352 1.9× 183 1.3× 45 1.4k
Elisa Rivas Spain 7 573 0.7× 1.0k 1.5× 455 1.2× 255 1.4× 72 0.5× 7 1.4k

Countries citing papers authored by Chahrazade Kantari‐Mimoun

Since Specialization
Citations

This map shows the geographic impact of Chahrazade Kantari‐Mimoun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chahrazade Kantari‐Mimoun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chahrazade Kantari‐Mimoun more than expected).

Fields of papers citing papers by Chahrazade Kantari‐Mimoun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chahrazade Kantari‐Mimoun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chahrazade Kantari‐Mimoun. The network helps show where Chahrazade Kantari‐Mimoun may publish in the future.

Co-authorship network of co-authors of Chahrazade Kantari‐Mimoun

This figure shows the co-authorship network connecting the top 25 collaborators of Chahrazade Kantari‐Mimoun. A scholar is included among the top collaborators of Chahrazade Kantari‐Mimoun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chahrazade Kantari‐Mimoun. Chahrazade Kantari‐Mimoun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Li, Shamin, Chahrazade Kantari‐Mimoun, Samantha Knockaert, et al.. (2024). In silico and pharmacological evaluation of GPR65 as a cancer immunotherapy target regulating T-cell functions. Frontiers in Immunology. 15. 1483258–1483258. 2 indexed citations
2.
Kantari‐Mimoun, Chahrazade, Sarah Barrin, Lene Vimeux, et al.. (2021). CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1. Cancer Immunology Research. 9(12). 1425–1438. 51 indexed citations
3.
Nicolás‐Boluda, Alba, Javier Vaquero, Lene Vimeux, et al.. (2021). Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment. eLife. 10. 215 indexed citations breakdown →
4.
Kantari‐Mimoun, Chahrazade, Sarah Barrin, Lene Vimeux, et al.. (2021). CAR T-cell Entry into Tumor Islets Is a Two-Step Process Dependent on IFNγ and ICAM-1.. PubMed. 9(12). 1425–1438. 41 indexed citations
5.
Peranzoni, Elisa, Jean Lemoine, Lene Vimeux, et al.. (2018). Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment. Proceedings of the National Academy of Sciences. 115(17). E4041–E4050. 631 indexed citations breakdown →
6.
Lafont, Élodie, Chahrazade Kantari‐Mimoun, Peter Dráber, et al.. (2017). The linear ubiquitin chain assembly complex regulates TRAIL ‐induced gene activation and cell death. The EMBO Journal. 36(9). 1147–1166. 91 indexed citations
7.
Krzywińska, Ewelina, Chahrazade Kantari‐Mimoun, Yann M. Kerdiles, et al.. (2017). Loss of HIF-1α in natural killer cells inhibits tumour growth by stimulating non-productive angiogenesis. Nature Communications. 8(1). 1597–1597. 133 indexed citations
8.
Kantari‐Mimoun, Chahrazade, Ewelina Krzywińska, Magali Castells, et al.. (2017). Boosting the hypoxic response in myeloid cells accelerates resolution of fibrosis and regeneration of the liver in mice. Oncotarget. 8(9). 15085–15100. 15 indexed citations
9.
Martin, Katherine, Chahrazade Kantari‐Mimoun, Min Yin, et al.. (2016). Proteinase 3 Is a Phosphatidylserine-binding Protein That Affects the Production and Function of Microvesicles. Journal of Biological Chemistry. 291(20). 10476–10489. 39 indexed citations
10.
Klose, Ralph, Ewelina Krzywińska, Magali Castells, et al.. (2016). Targeting VEGF-A in myeloid cells enhances natural killer cell responses to chemotherapy and ameliorates cachexia. Nature Communications. 7(1). 12528–12528. 32 indexed citations
11.
Kantari‐Mimoun, Chahrazade, Magali Castells, Ralph Klose, et al.. (2014). Resolution of liver fibrosis requires myeloid cell–driven sinusoidal angiogenesis. Hepatology. 61(6). 2042–2055. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liangrong Shi Breakdown of academic impact, for papers by Ivy X. Chen Breakdown of academic impact, for papers by Boxuan Zhou Breakdown of academic impact, for papers by Crescenzo D’Alterio Breakdown of academic impact, for papers by Kabir A. Khan Breakdown of academic impact, for papers by Adrià Cañellas‐Socias Breakdown of academic impact, for papers by Yosra Messai Breakdown of academic impact, for papers by Jordi Badia-Ramentol Breakdown of academic impact, for papers by Ai Sato Breakdown of academic impact, for papers by Elisa Rivas
Rankless by CCL
2026